Less than 24 hours to go…
Nov 02, 2020•45 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
It’s the eve of the election, and a lot is at stake for investors.
From tech regulation, to taxes and energy policy, there’s a ton riding on the outcome.
We’ll follow everything you need to know – including the record money pouring into campaigns, and all the possible outcomes for stocks in the coming days.
Plus, our own Meg Tirrell explains why Regeneron’s promising COVID-19 antibody treatment would be in short supply if the FDA approved it today.
For the best experience, listen in Metacast app for iOS or Android